Skip to content

THERMAGE FLX TT0.25F6-225Recalls & reported problems

Solta Medical · FLX TREATMENT TIP, EYE, 0.25CM2, 225 REP · Class 1

All models of THERMAGE FLX (8)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00816995021346), received between Jul 2, 2024 and Nov 11, 2025 — classified as 3 injuries.

The most frequently reported specific device problem is “Radiation Output Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Radiation Output Problem1
  • Wireless Communication Problem1

Patient problems

  • Burn(s)2
  • Blister1
  • Cyst(s)1
  • Erythema1
  • Hyperpigmentation1
  • Subcutaneous Nodule1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 11, 2025Radiation Output Problem; Radiation Output Problem

    PER THE MOST RECENT FOLLOW-UP, THE TREATING FACILITY INDICATED THAT THERE IS A HIGH LIKELIHOOD OF PERMANENT SCARRING.

    Patient problems: Blister; Burn(s)

    MAUDE report 23525966 ↗
  • InjuryNov 22, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A USER FACILITY REPORTED THAT A PATIENT EXPERIENCED A SUBCUTANEOUS CYSTIC NODULE UNDER THEIR RIGHT EYE FOLLOWING A THERMAGE FLX TREATMENT. SOLTA MEDICAL BRANDED CRYOGEN AND AN UNKNOWN AMOUNT OF COUPLING FLUID WAS USED WITH THE HIGHEST LEVEL OF TREATMENT AT 2.5. EYE SHIELDS WERE INSERTED USING NEODEX EYE SHIELD LUBRICATION. THE PATIENT RECEIVED TREATMENT TO THEIR EYELIDS AND FACE WITH NO EQUIPMENT PROBLEMS AND NO PROCEDURE ISSUES. THIS WAS THE FIRST TIME THE TREATMENT TIP WAS USED ON A PATIENT, AND IT WAS INSPECTED PRIOR TO THE PROCEDURE WITH NO DISCREPANCIES OBSERVED. THE TIP WAS NOT CHECKED AT ANY TIME DURING THE TREATMENT. THE PATIENT HAD RECEIVED LDM (LOCAL DYNAMIC MICRO-MASSAGE) ULTRASOUND TREATMENT IN THE SAME SYMPTOM AREA ON THE PROCEDURE DATE BUT DID NOT UNDERGO ANY OTHER TREATMENT WITHIN 30 DAYS PRIOR. APPROXIMATELY 21 DAYS POST-PROCEDURE THE PATIENT VISITED THE HOSPITAL WITH A COMPLAINT OF A SUBCUTANEOUS CYSTIC NODULE IN THE RIGHT ORBITAL REGION. A CYSTIC LESION MEASURING 6X3X5MM WAS CONFIRMED AND IT WAS PRESUMED THAT IT MAY BE AN EPIDERMAL CYST INDUCED BY EXTERNAL STIMULI. THE USER FACILITY DETERMINED SINCE NO PROBLEMS OCCURRED DURING THE THERMAGE FLX PROCEDURE, AND IT WA

    Patient problems: Cyst(s); Subcutaneous Nodule

    MAUDE report 20763698 ↗
  • InjuryJul 2, 2024Wireless Communication Problem; Wireless Communication Problem

    IT WAS REPORTED THAT A PATIENT EXPERIENCED BURNS ON THE LOWER EYELID AFTER A THERMAGE FLX EYE TREATMENT. AN EYE SHIELD WAS USED TREATMENT DURING THE TREATMENT. THE DOCTOR REPORTED HAVING TROUBLE WITH THE TREATMENT AND COULD NOT PROGRESS AFTER 23 REPS DUE TO RECEIPT OF A RADIOFREQUENCY POWER ERROR/TUNING FAILURE. THE HIGHEST ENERGY LEVEL USED WAS 2.0. NO ADDITIONAL TREATMENTS WERE BEING PERFORMED AT THE SAME TIME AS THE THERMAGE FLX TREATMENT. SOLTA MEDICAL CRYOGEN AND COUPLING FLUID (1ML) WERE USED FOR THE TREATMENT. THIS WAS THE INITIAL USE OF THE TREATMENT TIP, WHICH WAS INSPECTED PRIOR TO TREATMENT BUT NOT THROUGHOUT THE TREATMENT. NO SECONDARY INTERVENTION WAS NECESSARY AS A RESULT OF THE BURN. TWO AVAILABLE PICTURES WERE REVIEWED BY THE SOLTA MEDICAL REVIEWER. THE SEQUENCE OF PICTURES AND TIMING ARE UNCLEAR; THEREFORE, THE HEALING PROCESS CANNOT BE DETERMINED. ONE PICTURE SHOWS MINOR CRUSTS UNDER EYELID WITH ERYTHEMA ON THE CHEEK, AND THE SECOND PICTURE SHOWS A HYPERPIGMENTED LINE UNDER THE EYELID AND MINOR ERYTHEMA ON THE CHEEK. THOUGH REQUESTED, NO ADDITIONAL INFORMATION HAS BEEN RECEIVED. THE PATIENT¿S CURRENT STATUS IS UNKNOWN AND IT IS UNKNOWN IF THERE WILL BE PERMANENT D

    Patient problems: Burn(s); Erythema; Hyperpigmentation

    MAUDE report 19660793 ↗

Other Massager, Therapeutic, Electric devices

All Massager, Therapeutic, Electric devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page